Penghua CSI Chinese Medicine ETF (159647) rose 1.30%, with the latest price at RMB 0.94

NewTimeSpace News, as of 14:17 on August 13, 2026, Penghua CSI Chinese Medicine ETF (159647) rose 1.30%, with the latest price at RMB 0.94. Over a longer horizon, as of August 12, 2026, Penghua CSI Chinese Medicine ETF has gained a cumulative 6.68% over the past 1 month.

In terms of liquidity, Penghua CSI Chinese Medicine ETF recorded an intraday turnover rate of 3.62% with a turnover of RMB 37.2703 million. Over a longer horizon, as of August 12, the ETF's average daily turnover over the past 1 week was RMB 132 million, ranking first among comparable funds.

In terms of size, Penghua CSI Chinese Medicine ETF's scale grew by RMB 279 million over the past 1 year, achieving significant growth, with the newly added AUM ranking 1st out of 4 among comparable funds. (Data source: Wind)

In terms of shares outstanding, Penghua CSI Chinese Medicine ETF's shares increased by 392 million over the past 1 year, achieving significant growth, with the newly added shares ranking 2nd out of 4 among comparable funds. (Data source: Wind)

Data shows that leveraged funds continue to build positions. Penghua CSI Chinese Medicine ETF's latest margin buying amount reached RMB 1.0744 million, and its latest margin balance reached RMB 17.9515 million. (Data source: Wind)

In terms of return capability, as of August 12, 2026, since its inception, Penghua CSI Chinese Medicine ETF has achieved a highest monthly return of 16.26%, a longest streak of consecutive monthly gains of 5 months, a longest cumulative gain during a winning streak of 20.28%, and an average return in up months of 5.45%. As of August 12, 2026, Penghua CSI Chinese Medicine ETF's annualized excess return over the benchmark over the past 3 months was 7.24%, ranking among the top 2 out of 4 among comparable funds.

In terms of drawdown, as of August 12, 2026, Penghua CSI Chinese Medicine ETF's drawdown relative to the benchmark over the past half year was 0.07%, the smallest among comparable funds.

In terms of fees, Penghua CSI Chinese Medicine ETF has a management fee rate of 0.50% and a custodian fee rate of 0.10%, the lowest fee rate among comparable funds.

In terms of tracking accuracy, as of August 12, 2026, Penghua CSI Chinese Medicine ETF's tracking error over the past 1 year was 0.046%, the highest tracking accuracy among comparable funds.

From a valuation perspective, the CSI Chinese Medicine Index tracked by Penghua CSI Chinese Medicine ETF has a latest price-to-earnings ratio (PE-TTM) of only 21.7x, standing at the 17% percentile over the past 1 year, which means the valuation is lower than over 83% of the time in the past 1 year, placing it at a historically low level.

Penghua CSI Chinese Medicine ETF closely tracks the CSI Chinese Medicine Index. The CSI Chinese Medicine Index selects securities of listed companies whose businesses involve the production and sales of traditional Chinese medicine as samples, so as to reflect the overall performance of traditional-Chinese-medicine-themed listed companies.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.